BIRC5 and neoplasm: BIRC5 is a potential biomarker and inducer of myeloid-derived suppressor cell (MDSC) infiltration in HCC, leading to T cell rejection or dysfunction of the tumor immune microenvironment, ultimately reducing the response to immune checkpoint inhibitors (ICIs)77.